Talking it out: team approach may ease tough cancer decisions
NCT ID NCT07164365
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether an extra meeting with a team of doctors, a palliative care specialist, and a psychologist can help patients with advanced cancer feel less torn about their next treatment. 62 adults with metastatic lung, breast, colon, ovarian, or prostate cancer who need a third round of therapy will be randomly assigned to standard care or the extra team talk. The goal is to see if this shared decision-making approach reduces decisional conflict and improves satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Interdisciplinary shared decision-making consultation (behavioral intervention)
- What this could lead to
- If successful, this approach could help patients with advanced cancer feel more confident and less conflicted about their treatment choices.
- What could go wrong
- This is a small, early-stage study with only 62 participants, so results may not apply broadly. The intervention is behavioral, not a drug, so it won't change the disease itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DECISIONAL CONFLICT, ADVANCED/METASTATIC SOLID TUMORS, SHARED DECISION-MAKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario San Ignacio
Bogotá, Bogota D.C., 111111, Colombia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chemo combo vs. radioactive drug: which tames aggressive prostate cancer?
- Can delivering cancer drug directly to the liver shrink tumors?
- Can a blood filtering technique reveal more about prostate cancer spread?
- Can a Two-Drug attack shrink Hard-to-Treat breast cancer?
- Blood biomarkers could replace invasive biopsies for colorectal cancer monitoring
- Can a vaccine plus immune booster tackle resistant prostate cancer?